Pneumonia subtypes based on lung bacteria
Part of Infections, Lungs & breathing clinical trials.
This study looks at the germs in your lungs to understand why some people's pneumonia doesn't get better with standard antibiotics. If you are hospitalized with pneumonia and have just started treatment, you may be asked to provide a sputum sample so researchers can study your lung microbiome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have pneumonia confirmed by a chest X-ray or CT scan.
- You must have started antibiotics for this pneumonia less than 24 hours ago.
- You must be able to produce a sputum (phlegm) sample, or if you're in the ICU, a sample can be taken from your lungs.
- You cannot have AIDS, be on chemotherapy, or have had a bone marrow transplant.
- You cannot be taking high doses of steroids (more than 2 mg per kg of prednisone per day).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This study looks at adults with pneumonia caught outside the hospital. It aims to understand what symptoms they have and how well they recover, which could help doctors treat this condition better.
This study looks at how certain parts of the bacteria that cause pneumonia (called virulence factors) and your body's natural inflammation markers are related to how well you recover. The goal is to learn more about what affects pneumonia outcomes, which could help doctors personalize treatment.
This study looks at how hospital-acquired pneumonia is diagnosed and treated in Chinese hospitals. If you have this type of pneumonia, you may be able to join and help improve care.
This study looks at how severe pneumonia acquired outside of a hospital is currently treated, to better understand the illness and improve care. It may help researchers develop better ways to diagnose and manage this serious lung infection.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
Hear when a new Community Acquired or Acquiring Hospital Acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.